🔎 Trials Near Me

Почетна › Hronična limfocitna leukemija › Северна Каролина › Winston-Salem

Kliničke studije za Hronična limfocitna leukemija u gradu Winston-Salem, NC

9 studija za Hronična limfocitna leukemija traži učesnike na lokacijama u gradu Winston-Salem i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Тражи се учесникФаза 2
  • Novant Health Cancer Institute, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07221500

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Тражи се учесникФаза 1/2
  • Research Site, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06564038

MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab

Тражи се учесникФаза 2
  • Research Site, Winston-Salem
Узраст од 18 до 130 · Оба пола · Ажурирано 23. 10. 2026. · NCT07024706

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Тражи се учесникФаза 3
  • Atrium Health Wake Forest Baptist, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06943872

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Тражи се учесникФаза 1/2
  • Research Site, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT06542250

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Тражи се учесникФаза 3
  • Atrium Health Wake Forest Baptist, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06973187

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Тражи се учесникОпсервациона студија
  • Wake Forest Baptist Health, Winston-Salem
Узраст од 18 до 120 · Оба пола · Ажурирано 13. 4. 2026. · NCT01890486

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Тражи се учесникФаза 3
  • Atrium Health Wake Forest Baptist Medical Center /ID# 273142, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT06428019

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Тражи се учесникФаза 2
  • Novant Health Forsyth Medical Center /ID# 249533, Winston-Salem
Узраст 18 и старији · Оба пола · Ажурирано 9. 2. 2026. · NCT04895436

Studije za Hronična limfocitna leukemija u drugim gradovima

Ostale studije u gradu Winston-Salem

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.